Deutsche Bank raised the firm’s price target on Boston Scientific to $73 from $63 and keeps a Hold rating on the shares following the Q1 “beat and raise.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific sees FY24 adjusted EPS $2.29-$2.34, consensus $2.25
- Boston Scientific sees Q2 adjusted EPS 57c-59c, consensus 56c
- Boston Scientific reports Q1 adjusted EPS 56c, consensus 51c
- Boston Scientific Announces Results for First Quarter 2024
- Notable companies reporting before tomorrow’s open